We are live on ! Find out more
ACM

Alta Capital Management Portfolio holdings

AUM $1.29B
1-Year Est. Return 17.57%
This Fund
S&P 500
This Quarter Est. Return
+13.19%
1 Year Est. Return
+17.57%
3 Year Est. Return
+68.18%
5 Year Est. Return
+71.59%
10 Year Est. Return
+290.58%
AUM
$974M
AUM Growth
+$143M
Cap. Flow
+$36.2M
Cap. Flow %
3.72%
Top 10 Hldgs %
34.28%
Holding
100
New
13
Increased
69
Reduced
6
Closed
6

Top Buys

Rank Stock Value
1
BHC icon
Bausch Health
BHC
+$2.49M
2
AGN
Allergan plc
AGN
+$2.27M
3
V icon
Visa
V
+$1.89M
4
NVO
Novo Nordisk
NVO
+$1.78M
5
AAPL icon
Apple
AAPL
+$1.75M

Sector Composition

Rank Sector Weight
1 Healthcare 17.75%
2 Technology 17.16%
3 Industrials 13.49%
4 Financials 13.43%
5 Consumer Discretionary 12.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.8T
$53.7M 5.51%
2,681,896
+92,372
+4% +$1.75M
BKNG icon
2
Booking.com
BKNG
$139B
$38.5M 3.95%
827,450
-3,200
-0.4% -$142K
NVO
3
Novo Nordisk
NVO
$219B
$35.3M 3.62%
1,911,040
+102,400
+6% +$1.78M
V icon
4
Visa
V
$686B
$32.9M 3.38%
591,356
+37,440
+7% +$1.89M
BHC icon
5
Bausch Health
BHC
$1.75B
$30.6M 3.15%
261,063
+22,746
+10% +$2.49M
QCOM icon
6
Qualcomm
QCOM
$180B
$29.2M 3%
393,241
+14,108
+4% +$995K
RTX icon
7
RTX Corp
RTX
$262B
$29M 2.98%
405,564
+7,958
+2% +$542K
ECL icon
8
Ecolab
ECL
$75.6B
$28.6M 2.93%
274,005
+2,417
+0.9% +$251K
MA icon
9
Mastercard
MA
$484B
$28.2M 2.9%
337,860
-18,060
-5% -$1.34M
ORCL icon
10
Oracle
ORCL
$350B
$27.9M 2.86%
728,404
+13,387
+2% +$460K
DLTR icon
11
Dollar Tree
DLTR
$24.3B
$27.2M 2.8%
482,804
+25,913
+6% +$1.49M
GOOG icon
12
Alphabet (Google) Class C
GOOG
$4.29T
$27.1M 2.78%
970,946
+36,376
+4% +$920K
TJX icon
13
TJX Companies
TJX
$172B
$26.5M 2.72%
833,198
+53,772
+7% +$1.63M
PEP icon
14
PepsiCo
PEP
$185B
$26.2M 2.69%
315,590
+11,144
+4% +$925K
TMO icon
15
Thermo Fisher Scientific
TMO
$196B
$25.3M 2.6%
227,100
+5,007
+2% +$498K
LKQ icon
16
LKQ Corp
LKQ
$6.38B
$25.2M 2.59%
766,712
+25,706
+3% +$839K
CTSH icon
17
Cognizant
CTSH
$21.1B
$25.2M 2.58%
498,754
+17,346
+4% +$790K
PRGO icon
18
Perrigo
PRGO
$1.47B
$25M 2.57%
163,126
+2,558
+2% +$369K
APH icon
19
Amphenol
APH
$185B
$24.8M 2.55%
2,227,456
+80,968
+4% +$837K
PCP
20
DELISTED
PRECISION CASTPARTS CORP
PCP
$24.7M 2.54%
91,900
+2,700
+3% +$679K
PSX icon
21
Phillips 66
PSX
$83.7B
$24.5M 2.52%
317,922
+14,492
+5% +$967K
COP icon
22
ConocoPhillips
COP
$141B
$24.3M 2.5%
344,392
+7,612
+2% +$547K
WFC icon
23
Wells Fargo
WFC
$261B
$24.2M 2.48%
532,482
+24,301
+5% +$1.05M
ESRX
24
DELISTED
Express Scripts Holding Company
ESRX
$23.7M 2.44%
338,097
+20,455
+6% +$1.34M
LECO icon
25
Lincoln Electric
LECO
$13.4B
$23.2M 2.39%
325,855
+2,418
+0.7% +$170K

Similar funds

Alta Capital Management's Q4 2013 Portfolio in Review

As of Q4 2013, Alta Capital Management held 100 positions worth $974M, up 17% from $832M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Alta Capital Management deployed $36.2M of net new capital in Q4 2013, opening 13 new positions and adding to 69 existing holdings. Its largest new stake was Allergan plc: 14,504 shares worth $2.44M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Mastercard, an estimated $1.34M trimmed.

  • Alta Capital Management's largest Q4 2013 buy was Allergan plc: 14,504 shares worth $2.44M.
  • Alta Capital Management added most to Bausch Health in Q4 2013, an estimated $2.49M increase.
  • Alta Capital Management's biggest Q4 2013 reduction was Mastercard, cutting an estimated $1.34M.
  • Alta Capital Management fully exited Johnson & Johnson in Q4 2013, selling an estimated $742K.
  • Alta Capital Management's ten largest holdings make up 34% of its $974M portfolio in Q4 2013.
  • Alta Capital Management opened 13 new positions and closed 6 in Q4 2013.
  • Alta Capital Management's portfolio value rose 17% quarter-over-quarter to $974M.

Based on Alta Capital Management's 13F filing for Q4 2013, filed 22 Jan 2014.